← k3vl4r
Log inGet started →

REGN (Regeneron Pharmaceuticals) Price Forecast

AI-generated price forecast for Regeneron Pharmaceuticals (REGN) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of November 2026: K3vl4r's calibrated AI forecast currently reads REGN as 1/1 bullish across its horizons (1 of 1 timeframes pointing up), with a last price of 920.69. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP🔬 Deep research

Last price

920.69

AI outlook

1/1 bullish

Timeframes up

1 / 1

Share𝕏PostTelegram

REGN forecast by horizon

HorizonDirectionCalibrated move (end of horizon)
1-hour——
4-hour——
Daily~4 weeks out▲ Up+30.54%
WeeklyNot enough track record yet—

Calibrated: each horizon's forecast is weighted by how often the model has called REGN's direction correctly over the last 30 days, and reversed where it has been wrong more often than right. A horizon votes only once it has enough resolved forecasts.

Congressional trades in REGN

Public STOCK Act disclosures · amounts are ranges, reported up to ~45 days after the trade.

MemberActionDateAmount
Alan Armstrong▲ Buy2026-03-27$1001–15000

Track what Congress is trading across the whole market in the app — get started free.

Latest REGN news

From the market-news feed the forecasts are read against.

  • Alnylam (ALNY) Stock Looks Undervalued As Shares Fell 68% · Yahoo · Nov 19
  • Alnylam Pharmaceuticals (ALNY) Stock Dropped, So What Is Driving Attention Now? · Yahoo · Nov 19
  • With FDA nod, Regeneron brings an RNAi drug to autoimmune disease · Yahoo · Nov 19
  • REGN Gets FDA Nod for Livsayis in Generalized Myasthenia Gravis · Yahoo · Nov 19
  • Regeneron Wins FDA Nod For Livsayis, 4x-Year GMG Shot · Yahoo · Nov 19

🔒

See the full REGN forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

REGN forecast — frequently asked

Will REGN go up?

K3vl4r's calibrated AI forecast currently reads REGN as 1/1 bullish — 1 of 1 forecast horizons point up, so the overall read is leaning to the upside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the REGN price prediction for 2026?

K3vl4r's model projects REGN toward $1,202 over the next ~4 weeks, a +30.5% move from $920.69. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Biotech & Pharma forecasts — browse the full sector.

More AI forecasts

IRWDTMDXAMGNSRPTBIIBNVAXINCYFATEGILDBCRXUTHRCDNAPRTANTLA

Will REGN reach…?

Will REGN reach $2,000?Will REGN reach $2,500?Will REGN reach $5,000?

Or see the full REGN price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare REGN

REGN vs IRWDREGN vs TMDXREGN vs AMGNREGN vs SRPTREGN vs BIIBREGN vs NVAX

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rResearch libraryTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.